| Customization: | Available |
|---|---|
| Powder: | Yes |
| Certification: | ISO 9001, FDA |
|
Still deciding? Get samples of US$ 260/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| product name | Baloxavir marboxil |
| CAS NO. | 1985606-14-1 |
| Specification | 99% |
| Appearance | White powder |
| packing | 1kg/bag,25kgs/drum |
| MOQ | 1KG |
Baloxavir marboxil blocks viral mRNA synthesis by inhibiting cap-dependent endonuclease activity, and blocks directly at the viral replication stage.
Mabaloxavir tablets are 20mg and 40mg tablets, mainly suitable for previously healthy adults and children aged 5 years and above with simple influenza A and B, or adults and children aged 12 years and above with influenza at high risk of influenza-related complications. Common adverse reactions of this drug include diarrhea, bronchitis, nausea, sinusitis and headache. Mabaloxavir tablets are contraindicated in patients with known allergies to this product or any excipients.
| Item | Specification | Test result |
| Appearance | white powder | Conforms |
| Assay | 99% | Conforms |
| Heavy metal | ≤10ppm | Conforms |
| Lead | ≤2.0ppm | Conforms |
| As | ≤2.0ppm | Conforms |
| Ca | ≤1.0ppm | Conforms |
| Me | ≤0.1ppm | Conforms |
| Total aerobic microbial count | ≤1000CFU/g | Conforms |
| Total moulds&yeast count | ≤100CFU/g | Conforms |
| Enterobacterial | ≤10MPN/g | Conforms |
| Salmonella | N.D/25g | Conforms |
| Escherichia coli | N.D/10g | Conforms |
| Staphylococcus aureus | N.D/10g | Conforms |
| Pseudomonas aeruginosa | N.D/10g | Conforms |
| Conclusion: Conform with specification. | ||
){kind=link}